Does IRBESARTAN Cause Thrombocytopenia? 103 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 103 reports of Thrombocytopenia have been filed in association with IRBESARTAN (Irbesartan). This represents 1.0% of all adverse event reports for IRBESARTAN.
103
Reports of Thrombocytopenia with IRBESARTAN
1.0%
of all IRBESARTAN reports
21
Deaths
60
Hospitalizations
How Dangerous Is Thrombocytopenia From IRBESARTAN?
Of the 103 reports, 21 (20.4%) resulted in death, 60 (58.3%) required hospitalization, and 9 (8.7%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for IRBESARTAN.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which IRBESARTAN Alternatives Have Lower Thrombocytopenia Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE